EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases

Cheng Yang, Cheng-Gang Zhu, Yuan-Lin Guo, Na-Qiong Wu, Qian Dong, Rui-Xia Xu, Yong-Jian Wu, Jie Qian, Jian-Jun Li

Diabetes & Metabolism Journal · 2024

DOI: 10.4093/dmj.2023.0410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, 2024. Verfasst von Cheng Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Hauptthemen laut MEDLINE: Endothelin-1, Prediabetic State, Coronary Artery Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endothelin-1 (ET-1) is an endogenous vasoconstrictor implicated in coronary artery disease (CAD) and diabetes. This study aimed to determine the prognostic value of ET-1 in the patients with stable CAD under different glucose metabolism states.

Methods

In this prospective, large-cohort study, we consecutively enrolled 7,947 participants with angiography-diagnosed stable CAD from April 2011 to April 2017. Patients were categorized by baseline glycemic status into three groups (normoglycemia, prediabetes, and diabetes) and further divided into nine groups by circulating ET-1 levels. Patients were followed for the occurrence of cardiovascular events (CVEs), including nonfatal myocardial infarction, stroke, and cardiovascular mortality.

Results

Of the 7,947 subjects, 3,352, 1,653, and 2,942 had normoglycemia, prediabetes, and diabetes, respectively. Over a median follow-up of 37.5 months, 381 (5.1%) CVEs occurred. The risk for CVEs was significantly higher in patients with elevated ET-1 levels after adjustment for potential confounders. When patients were categorized by both status of glucose metabolism and plasma ET-1 levels, the high ET-1 levels were associated with higher risk of CVEs in prediabetes (adjusted hazard ratio [HR], 2.089; 95% confidence interval [CI], 1.151 to 3.793) and diabetes (adjusted HR, 2.729; 95% CI, 1.623 to 4.588; both P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelin-1Prediabetic StateCoronary Artery DiseaseHumansFemaleMalePrognosisMiddle AgedProspective StudiesAgedBlood GlucoseDiabetes MellitusBiomarkersRisk FactorsFollow-Up Studies

Stichwörter der Autor:innen

Coronary artery diseaseDiabetes mellitusEndothelin-1Prediabetic statePrognosis

Substanzen

Endothelin-1Blood GlucoseBiomarkers

Autor:innen und Institutionen

  • Cardiometabolic Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Förderung

  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Yang, C., Zhu, C. G., Guo, Y. L., Wu, N. Q., Dong, Q., Xu, R. X., Wu, Y. J., Qian, J., & Li, J. J. (2024). Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2023.0410

Vancouver

Yang C, Zhu CG, Guo YL, Wu NQ, Dong Q, Xu RX, et al. Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases. Diabetes & Metabolism Journal. 2024. doi:10.4093/dmj.2023.0410

BibTeX
@article{Yang2024,
  author = {Yang, Cheng and Zhu, Cheng-Gang and Guo, Yuan-Lin and Wu, Na-Qiong and Dong, Qian and Xu, Rui-Xia and Wu, Yong-Jian and Qian, Jie and Li, Jian-Jun},
  title = {Prognostic Value of Plasma Endothelin-1 in Predicting Worse Outcomes in Patients with Prediabetes and Diabetes and Stable Coronary Artery Diseases},
  journal = {Diabetes & Metabolism Journal},
  year = {2024},
  doi = {10.4093/dmj.2023.0410}
}
Kostenlos starten →